Zenotech Laboratories
44.54
0.00(0.00%)
Market Cap₹271.80 Cr
PE Ratio-108.63
IndustryHealthcare
Company Performance:
1D0.00%
1M-0.13%
6M-0.49%
1Y-24.95%
5Y-20.89%
View Company Insightsright
More news about Zenotech Laboratories
31Oct 25
Zenotech Laboratories Reports Mixed Q2 Results with Revenue Growth and Net Loss
Zenotech Laboratories Limited reported Q2 FY2024 results with revenue from operations at Rs. 1,023.19 lakhs, up 17% year-over-year. Despite revenue growth, the company posted a net loss of Rs. 83.65 lakhs for the quarter, compared to a profit of Rs. 134.74 lakhs in Q2 FY2023. Half-year results showed a modest profit of Rs. 15.30 lakhs. The company opted for a concessional tax rate and settled export obligation liabilities. Total assets stood at Rs. 11,092.39 lakhs with Rs. 3,160.98 lakhs in cash and cash equivalents.
 no imag found
28Jul 25
Zenotech Laboratories Reports Q1 Results, Appoints New Statutory Auditors
Zenotech Laboratories Limited reported Q1 financial results with total income of Rs 1,023.16 lakhs, slightly down from Rs 1,024.96 lakhs year-over-year. Net profit decreased by 23.27% to Rs 98.96 lakhs. The company appointed M/s. G S K A & Co. as new statutory auditors for a five-year term, subject to shareholder approval. The 36th Annual General Meeting is scheduled for September 26.
 no imag found
1 Year Returns:-24.95%
Industry Peers
Sun Pharmaceutical
1,990.50
(-0.53%)
Divis Laboratories
8,056.00
(+2.82%)
Torrent Pharmaceuticals
5,122.80
(+5.15%)
Cipla
1,473.20
(+0.46%)
Zydus Life Science
1,126.80
(+1.05%)
Lupin
2,415.00
(-0.26%)
Mankind Pharma
2,469.60
(-4.13%)
Laurus Labs
1,816.20
(+1.96%)
Dr Reddys Laboratories
1,148.10
(+0.29%)
Aurobindo Pharma
1,580.20
(+0.25%)